AustralieFrV1, PascalFrancis, Corpus, bibRecord, 000399

Evidence-based organization and patient safety strategies in European hospitals

Identifieur interne : 000399 ( PascalFrancis/Corpus ); précédent : 000398; suivant : 000400

Evidence-based organization and patient safety strategies in European hospitals

Auteurs : Rosa Sunol ; Cordula Wagner ; Onyebuchi A. Arah ; Charles D. Shaw ; Solvejg Kristensen ; Caroline A. Thompson ; Maral Dersarkissian ; Paul D. Bartels ; Holger Pfaff ; Mariona Secanell ; Nuria Mora ; Frantisek Vlcek ; Halina Kutaj-Wasikowska ; Basia Kutryba ; Philippe Michel ; Oliver Groene

Source :

International journal for quality in health care [ 1353-4505 ] ; 2014.

RBID : Pascal:14-0152847

Descripteurs français

Pascal (Inist)
- Iatrogène, Médecine factuelle, Organisation, Complication, Malade, Stratégie, Hôpital, Santé publique, Hospitalisation, Europe, Européen, Qualité, Amélioration, Gestion de la qualité, Pratique professionnelle, Variation, Recommandation, Soin, Efficacité, Sécurité du patient, Soins de santé.

English descriptors

KwdEn :
- Care, Complication, Efficiency, Europe, European, Evidence-based medicine, Healthcare, Hospital, Hospitalization, Iatrogenic, Improvement, Organization, Patient, Patient safety, Professional practice, Public health, Quality, Quality management, Recommendation, Strategy, Variations.

Abstract

Objective. To explore how European hospitals have implemented patient safety strategies (PSS) and evidence-based organization of care pathway (EBOP) recommendations and examine the extent to which implementation varies between countries and hospitals. Design. Mixed-method multilevel cross-sectional design in seven countries as part of the European Union-funded project 'Deepening our Understanding of Quality improvement in Europe' (DUQuE). Setting and participants. Seventy-four acute care hospitals with 292 departments managing acute myocardial infarction (AMI), hip fracture, stroke, and obstetric deliveries. Main outcome measure. Five multi-item composite measures-one generic measure for PSS and four pathway-specific measures for EBOP Results. Potassium chloride had only been removed from general medication stocks in 9.4-30.5% of different pathways wards and patients were adequately identified with wristband in 43.0-59.7%. Although 86.3% of areas treating AMI patients had immediate access to a specialist physician, only 56.0% had arrangements for patients to receive thrombolysis within 30 min of arrival at the hospital. A substantial amount of the total variance observed was due to between-hospital differences in the same country for PSS (65.9%). In EBOP, between-country differences play also an important role (10.1%) in AMI to 57.1% in hip fracture). Conclusions. There were substantial gaps between evidence and practice of PSS and EBOP in a sample of European hospitals and variations due to country differences are more important in EBOP than in PSS, but less important than within-country variations. Agencies supporting the implementation of PSS and EBOP should closely re-examine the effectiveness of their current strategies.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 1353-4505`
A03		`1`		`@0 Int. j. qual. health care`
A05				`@2 26`
A06				`@3 SUP1`
A08	`01`	`1`	`ENG`	`@1 Evidence-based organization and patient safety strategies in European hospitals`
A09	`01`	`1`	`ENG`	`@1 How does Hospital Quality Management Drive Quality? Results fror the Deepening our Understanding of Quality Improvement (DUQuE) project`
A11	`01`	`1`		`@1 SUNOL (Rosa)`
A11	`02`	`1`		`@1 WAGNER (Cordula)`
A11	`03`	`1`		`@1 ARAH (Onyebuchi A.)`
A11	`04`	`1`		`@1 SHAW (Charles D.)`
A11	`05`	`1`		`@1 KRISTENSEN (Solvejg)`
A11	`06`	`1`		`@1 THOMPSON (Caroline A.)`
A11	`07`	`1`		`@1 DERSARKISSIAN (Maral)`
A11	`08`	`1`		`@1 BARTELS (Paul D.)`
A11	`09`	`1`		`@1 PFAFF (Holger)`
A11	`10`	`1`		`@1 SECANELL (Mariona)`
A11	`11`	`1`		`@1 MORA (Nuria)`
A11	`12`	`1`		`@1 VLCEK (Frantisek)`
A11	`13`	`1`		`@1 KUTAJ-WASIKOWSKA (Halina)`
A11	`14`	`1`		`@1 KUTRYBA (Basia)`
A11	`15`	`1`		`@1 MICHEL (Philippe)`
A11	`16`	`1`		`@1 GROENE (Oliver)`
A12	`01`	`1`		`@1 SCHNEIDER (Eric C.) @9 ed.`
A14	`01`			`@1 Avedis Donabedian Research Institute (FAD), Universitat Autonoma de Barcelona @3 ESP @Z 1 aut. @Z 10 aut. @Z 11 aut.`
A14	`02`			`@1 Red de investigación en servicios de salud en enfermedades crónicas REDISSEC @3 ESP @Z 1 aut. @Z 10 aut. @Z 11 aut.`
A14	`03`			`@1 NIVEL Netherlands Institute for Health Services Research @2 Utrecht @3 NLD @Z 2 aut.`
A14	`04`			`@1 Department of Public and Occupational Health, EMGO+ Institute for Health and Care Research, VU University Medical Center @2 Amsterdam @3 NLD @Z 2 aut.`
A14	`05`			`@1 Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA) @2 Los Angeles, CA @3 USA @Z 3 aut. @Z 6 aut. @Z 7 aut.`
A14	`06`			`@1 University of New South Wales @3 AUS @Z 4 aut.`
A14	`07`			`@1 Central Denmark Region & Center for Healthcare Improvements, Aalborg University @3 DNK @Z 5 aut.`
A14	`08`			`@1 Palo Alto Medical Foundation Research Institute @2 Palo Alto, CA @3 USA @Z 6 aut.`
A14	`09`			`@1 Central Denmark Region & The Department of Clinical Medicine, Aalborg University @3 DNK @Z 8 aut.`
A14	`10`			`@1 Institute of Medical Sociology, Health Services Research and Rehabilitation Science, University of Cologne @3 DEU @Z 9 aut.`
A14	`11`			`@1 Czech Accreditation Committee @3 CZE @Z 12 aut.`
A14	`12`			`@1 Polish Society for Quality Promotion in Health Care @3 POL @Z 13 aut. @Z 14 aut.`
A14	`13`			`@1 Quality and Safety Department, Lyon University, Hospital Network @3 FRA @Z 15 aut.`
A14	`14`			`@1 London School of Hygiene and Tropical Medicine @3 GBR @Z 16 aut.`
A15	`01`			`@1 RAND Boston @3 USA @Z 1 aut.`
A15	`02`			`@1 Division of General Medicine and Primary Care, Brigham and Women's Hospital and Harvard School of Public Health @3 USA @Z 1 aut.`
A17	`01`	`1`		`@1 DUQUE PROJECT CONSORTIUM @3 NLD`
A20				`@1 47-55`
A21				`@1 2014`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 22943 @5 354000502708920060`
A44				`@0 0000 @1 © 2014 INIST-CNRS. All rights reserved.`
A45				`@0 35 ref.`
A47	`01`	`1`		`@0 14-0152847`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 International journal for quality in health care`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 Objective. To explore how European hospitals have implemented patient safety strategies (PSS) and evidence-based organization of care pathway (EBOP) recommendations and examine the extent to which implementation varies between countries and hospitals. Design. Mixed-method multilevel cross-sectional design in seven countries as part of the European Union-funded project 'Deepening our Understanding of Quality improvement in Europe' (DUQuE). Setting and participants. Seventy-four acute care hospitals with 292 departments managing acute myocardial infarction (AMI), hip fracture, stroke, and obstetric deliveries. Main outcome measure. Five multi-item composite measures-one generic measure for PSS and four pathway-specific measures for EBOP Results. Potassium chloride had only been removed from general medication stocks in 9.4-30.5% of different pathways wards and patients were adequately identified with wristband in 43.0-59.7%. Although 86.3% of areas treating AMI patients had immediate access to a specialist physician, only 56.0% had arrangements for patients to receive thrombolysis within 30 min of arrival at the hospital. A substantial amount of the total variance observed was due to between-hospital differences in the same country for PSS (65.9%). In EBOP, between-country differences play also an important role (10.1%) in AMI to 57.1% in hip fracture). Conclusions. There were substantial gaps between evidence and practice of PSS and EBOP in a sample of European hospitals and variations due to country differences are more important in EBOP than in PSS, but less important than within-country variations. Agencies supporting the implementation of PSS and EBOP should closely re-examine the effectiveness of their current strategies.
C02	`01`	`X`		`@0 002B30A01D`
C02	`02`	`X`		`@0 002B30A11`
C03	`01`	`X`	`FRE`	`@0 Iatrogène @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Iatrogenic @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Iatrógeno @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Médecine factuelle @5 09`
C03	`02`	`X`	`ENG`	`@0 Evidence-based medicine @5 09`
C03	`02`	`X`	`SPA`	`@0 Medicina basada en pruebas @5 09`
C03	`03`	`X`	`FRE`	`@0 Organisation @5 10`
C03	`03`	`X`	`ENG`	`@0 Organization @5 10`
C03	`03`	`X`	`SPA`	`@0 Organización @5 10`
C03	`04`	`X`	`FRE`	`@0 Complication @5 11`
C03	`04`	`X`	`ENG`	`@0 Complication @5 11`
C03	`04`	`X`	`SPA`	`@0 Complicación @5 11`
C03	`05`	`X`	`FRE`	`@0 Malade @5 12`
C03	`05`	`X`	`ENG`	`@0 Patient @5 12`
C03	`05`	`X`	`SPA`	`@0 Enfermo @5 12`
C03	`06`	`X`	`FRE`	`@0 Stratégie @5 13`
C03	`06`	`X`	`ENG`	`@0 Strategy @5 13`
C03	`06`	`X`	`SPA`	`@0 Estrategia @5 13`
C03	`07`	`X`	`FRE`	`@0 Hôpital @5 14`
C03	`07`	`X`	`ENG`	`@0 Hospital @5 14`
C03	`07`	`X`	`SPA`	`@0 Hospital @5 14`
C03	`08`	`X`	`FRE`	`@0 Santé publique @5 15`
C03	`08`	`X`	`ENG`	`@0 Public health @5 15`
C03	`08`	`X`	`SPA`	`@0 Salud pública @5 15`
C03	`09`	`X`	`FRE`	`@0 Hospitalisation @5 16`
C03	`09`	`X`	`ENG`	`@0 Hospitalization @5 16`
C03	`09`	`X`	`SPA`	`@0 Hospitalización @5 16`
C03	`10`	`X`	`FRE`	`@0 Europe @2 NG @5 17`
C03	`10`	`X`	`ENG`	`@0 Europe @2 NG @5 17`
C03	`10`	`X`	`SPA`	`@0 Europa @2 NG @5 17`
C03	`11`	`X`	`FRE`	`@0 Européen @5 18`
C03	`11`	`X`	`ENG`	`@0 European @5 18`
C03	`11`	`X`	`SPA`	`@0 Europeo @5 18`
C03	`12`	`X`	`FRE`	`@0 Qualité @5 19`
C03	`12`	`X`	`ENG`	`@0 Quality @5 19`
C03	`12`	`X`	`SPA`	`@0 Calidad @5 19`
C03	`13`	`X`	`FRE`	`@0 Amélioration @5 20`
C03	`13`	`X`	`ENG`	`@0 Improvement @5 20`
C03	`13`	`X`	`SPA`	`@0 Mejora @5 20`
C03	`14`	`X`	`FRE`	`@0 Gestion de la qualité @5 21`
C03	`14`	`X`	`ENG`	`@0 Quality management @5 21`
C03	`14`	`X`	`SPA`	`@0 Gestión de calidad @5 21`
C03	`15`	`X`	`FRE`	`@0 Pratique professionnelle @5 22`
C03	`15`	`X`	`ENG`	`@0 Professional practice @5 22`
C03	`15`	`X`	`SPA`	`@0 Práctica profesional @5 22`
C03	`16`	`X`	`FRE`	`@0 Variation @5 23`
C03	`16`	`X`	`ENG`	`@0 Variations @5 23`
C03	`16`	`X`	`SPA`	`@0 Variación @5 23`
C03	`17`	`X`	`FRE`	`@0 Recommandation @5 24`
C03	`17`	`X`	`ENG`	`@0 Recommendation @5 24`
C03	`17`	`X`	`SPA`	`@0 Recomendación @5 24`
C03	`18`	`X`	`FRE`	`@0 Soin @5 25`
C03	`18`	`X`	`ENG`	`@0 Care @5 25`
C03	`18`	`X`	`SPA`	`@0 Cuidado @5 25`
C03	`19`	`X`	`FRE`	`@0 Efficacité @5 26`
C03	`19`	`X`	`ENG`	`@0 Efficiency @5 26`
C03	`19`	`X`	`SPA`	`@0 Eficacia @5 26`
C03	`20`	`X`	`FRE`	`@0 Sécurité du patient @4 CD @5 96`
C03	`20`	`X`	`ENG`	`@0 Patient safety @4 CD @5 96`
C03	`21`	`X`	`FRE`	`@0 Soins de santé @4 CD @5 97`
C03	`21`	`X`	`ENG`	`@0 Healthcare @4 CD @5 97`
C03	`21`	`X`	`SPA`	`@0 Asistencia sanitaria @4 CD @5 97`
C07	`01`	`X`	`FRE`	`@0 Pratique basée sur des preuves`
C07	`01`	`X`	`ENG`	`@0 Evidence-based practice`
C07	`01`	`X`	`SPA`	`@0 Práctica basada en la evidencia`
N21				`@1 195`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 14-0152847 INIST
ET :	Evidence-based organization and patient safety strategies in European hospitals
AU :	SUNOL (Rosa); WAGNER (Cordula); ARAH (Onyebuchi A.); SHAW (Charles D.); KRISTENSEN (Solvejg); THOMPSON (Caroline A.); DERSARKISSIAN (Maral); BARTELS (Paul D.); PFAFF (Holger); SECANELL (Mariona); MORA (Nuria); VLCEK (Frantisek); KUTAJ-WASIKOWSKA (Halina); KUTRYBA (Basia); MICHEL (Philippe); GROENE (Oliver); SCHNEIDER (Eric C.)
AF :	Avedis Donabedian Research Institute (FAD), Universitat Autonoma de Barcelona/Espagne (1 aut., 10 aut., 11 aut.); Red de investigación en servicios de salud en enfermedades crónicas REDISSEC/Espagne (1 aut., 10 aut., 11 aut.); NIVEL Netherlands Institute for Health Services Research/Utrecht/Pays-Bas (2 aut.); Department of Public and Occupational Health, EMGO+ Institute for Health and Care Research, VU University Medical Center/Amsterdam/Pays-Bas (2 aut.); Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA)/Los Angeles, CA/Etats-Unis (3 aut., 6 aut., 7 aut.); University of New South Wales/Australie (4 aut.); Central Denmark Region & Center for Healthcare Improvements, Aalborg University/Danemark (5 aut.); Palo Alto Medical Foundation Research Institute/Palo Alto, CA/Etats-Unis (6 aut.); Central Denmark Region & The Department of Clinical Medicine, Aalborg University/Danemark (8 aut.); Institute of Medical Sociology, Health Services Research and Rehabilitation Science, University of Cologne/Allemagne (9 aut.); Czech Accreditation Committee/Tchèque, République (12 aut.); Polish Society for Quality Promotion in Health Care/Pologne (13 aut., 14 aut.); Quality and Safety Department, Lyon University, Hospital Network/France (15 aut.); London School of Hygiene and Tropical Medicine/Royaume-Uni (16 aut.); RAND Boston/Etats-Unis (1 aut.); Division of General Medicine and Primary Care, Brigham and Women's Hospital and Harvard School of Public Health/Etats-Unis (1 aut.)
DT :	Publication en série; Niveau analytique
SO :	International journal for quality in health care; ISSN 1353-4505; Royaume-Uni; Da. 2014; Vol. 26; No. SUP1; Pp. 47-55; Bibl. 35 ref.
LA :	Anglais
EA :	Objective. To explore how European hospitals have implemented patient safety strategies (PSS) and evidence-based organization of care pathway (EBOP) recommendations and examine the extent to which implementation varies between countries and hospitals. Design. Mixed-method multilevel cross-sectional design in seven countries as part of the European Union-funded project 'Deepening our Understanding of Quality improvement in Europe' (DUQuE). Setting and participants. Seventy-four acute care hospitals with 292 departments managing acute myocardial infarction (AMI), hip fracture, stroke, and obstetric deliveries. Main outcome measure. Five multi-item composite measures-one generic measure for PSS and four pathway-specific measures for EBOP Results. Potassium chloride had only been removed from general medication stocks in 9.4-30.5% of different pathways wards and patients were adequately identified with wristband in 43.0-59.7%. Although 86.3% of areas treating AMI patients had immediate access to a specialist physician, only 56.0% had arrangements for patients to receive thrombolysis within 30 min of arrival at the hospital. A substantial amount of the total variance observed was due to between-hospital differences in the same country for PSS (65.9%). In EBOP, between-country differences play also an important role (10.1%) in AMI to 57.1% in hip fracture). Conclusions. There were substantial gaps between evidence and practice of PSS and EBOP in a sample of European hospitals and variations due to country differences are more important in EBOP than in PSS, but less important than within-country variations. Agencies supporting the implementation of PSS and EBOP should closely re-examine the effectiveness of their current strategies.
CC :	002B30A01D; 002B30A11
FD :	Iatrogène; Médecine factuelle; Organisation; Complication; Malade; Stratégie; Hôpital; Santé publique; Hospitalisation; Europe; Européen; Qualité; Amélioration; Gestion de la qualité; Pratique professionnelle; Variation; Recommandation; Soin; Efficacité; Sécurité du patient; Soins de santé
FG :	Pratique basée sur des preuves
ED :	Iatrogenic; Evidence-based medicine; Organization; Complication; Patient; Strategy; Hospital; Public health; Hospitalization; Europe; European; Quality; Improvement; Quality management; Professional practice; Variations; Recommendation; Care; Efficiency; Patient safety; Healthcare
EG :	Evidence-based practice
SD :	Iatrógeno; Medicina basada en pruebas; Organización; Complicación; Enfermo; Estrategia; Hospital; Salud pública; Hospitalización; Europa; Europeo; Calidad; Mejora; Gestión de calidad; Práctica profesional; Variación; Recomendación; Cuidado; Eficacia; Asistencia sanitaria
LO :	INIST-22943.354000502708920060
ID :	14-0152847

Links to Exploration step

Pascal:14-0152847

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Evidence-based organization and patient safety strategies in European hospitals</title>
<author><name sortKey="Sunol, Rosa" sort="Sunol, Rosa" uniqKey="Sunol R" first="Rosa" last="Sunol">Rosa Sunol</name>
<affiliation><inist:fA14 i1="01"><s1>Avedis Donabedian Research Institute (FAD), Universitat Autonoma de Barcelona</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Red de investigación en servicios de salud en enfermedades crónicas REDISSEC</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wagner, Cordula" sort="Wagner, Cordula" uniqKey="Wagner C" first="Cordula" last="Wagner">Cordula Wagner</name>
<affiliation><inist:fA14 i1="03"><s1>NIVEL Netherlands Institute for Health Services Research</s1>
<s2>Utrecht</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Department of Public and Occupational Health, EMGO+ Institute for Health and Care Research, VU University Medical Center</s1>
<s2>Amsterdam</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Arah, Onyebuchi A" sort="Arah, Onyebuchi A" uniqKey="Arah O" first="Onyebuchi A." last="Arah">Onyebuchi A. Arah</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA)</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Shaw, Charles D" sort="Shaw, Charles D" uniqKey="Shaw C" first="Charles D." last="Shaw">Charles D. Shaw</name>
<affiliation><inist:fA14 i1="06"><s1>University of New South Wales</s1>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kristensen, Solvejg" sort="Kristensen, Solvejg" uniqKey="Kristensen S" first="Solvejg" last="Kristensen">Solvejg Kristensen</name>
<affiliation><inist:fA14 i1="07"><s1>Central Denmark Region & Center for Healthcare Improvements, Aalborg University</s1>
<s3>DNK</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Thompson, Caroline A" sort="Thompson, Caroline A" uniqKey="Thompson C" first="Caroline A." last="Thompson">Caroline A. Thompson</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA)</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="08"><s1>Palo Alto Medical Foundation Research Institute</s1>
<s2>Palo Alto, CA</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dersarkissian, Maral" sort="Dersarkissian, Maral" uniqKey="Dersarkissian M" first="Maral" last="Dersarkissian">Maral Dersarkissian</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA)</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bartels, Paul D" sort="Bartels, Paul D" uniqKey="Bartels P" first="Paul D." last="Bartels">Paul D. Bartels</name>
<affiliation><inist:fA14 i1="09"><s1>Central Denmark Region & The Department of Clinical Medicine, Aalborg University</s1>
<s3>DNK</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pfaff, Holger" sort="Pfaff, Holger" uniqKey="Pfaff H" first="Holger" last="Pfaff">Holger Pfaff</name>
<affiliation><inist:fA14 i1="10"><s1>Institute of Medical Sociology, Health Services Research and Rehabilitation Science, University of Cologne</s1>
<s3>DEU</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Secanell, Mariona" sort="Secanell, Mariona" uniqKey="Secanell M" first="Mariona" last="Secanell">Mariona Secanell</name>
<affiliation><inist:fA14 i1="01"><s1>Avedis Donabedian Research Institute (FAD), Universitat Autonoma de Barcelona</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Red de investigación en servicios de salud en enfermedades crónicas REDISSEC</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mora, Nuria" sort="Mora, Nuria" uniqKey="Mora N" first="Nuria" last="Mora">Nuria Mora</name>
<affiliation><inist:fA14 i1="01"><s1>Avedis Donabedian Research Institute (FAD), Universitat Autonoma de Barcelona</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Red de investigación en servicios de salud en enfermedades crónicas REDISSEC</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vlcek, Frantisek" sort="Vlcek, Frantisek" uniqKey="Vlcek F" first="Frantisek" last="Vlcek">Frantisek Vlcek</name>
<affiliation><inist:fA14 i1="11"><s1>Czech Accreditation Committee</s1>
<s3>CZE</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kutaj Wasikowska, Halina" sort="Kutaj Wasikowska, Halina" uniqKey="Kutaj Wasikowska H" first="Halina" last="Kutaj-Wasikowska">Halina Kutaj-Wasikowska</name>
<affiliation><inist:fA14 i1="12"><s1>Polish Society for Quality Promotion in Health Care</s1>
<s3>POL</s3>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kutryba, Basia" sort="Kutryba, Basia" uniqKey="Kutryba B" first="Basia" last="Kutryba">Basia Kutryba</name>
<affiliation><inist:fA14 i1="12"><s1>Polish Society for Quality Promotion in Health Care</s1>
<s3>POL</s3>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Michel, Philippe" sort="Michel, Philippe" uniqKey="Michel P" first="Philippe" last="Michel">Philippe Michel</name>
<affiliation><inist:fA14 i1="13"><s1>Quality and Safety Department, Lyon University, Hospital Network</s1>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Groene, Oliver" sort="Groene, Oliver" uniqKey="Groene O" first="Oliver" last="Groene">Oliver Groene</name>
<affiliation><inist:fA14 i1="14"><s1>London School of Hygiene and Tropical Medicine</s1>
<s3>GBR</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">14-0152847</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0152847 INIST</idno>
<idno type="RBID">Pascal:14-0152847</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000399</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Evidence-based organization and patient safety strategies in European hospitals</title>
<author><name sortKey="Sunol, Rosa" sort="Sunol, Rosa" uniqKey="Sunol R" first="Rosa" last="Sunol">Rosa Sunol</name>
<affiliation><inist:fA14 i1="01"><s1>Avedis Donabedian Research Institute (FAD), Universitat Autonoma de Barcelona</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Red de investigación en servicios de salud en enfermedades crónicas REDISSEC</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wagner, Cordula" sort="Wagner, Cordula" uniqKey="Wagner C" first="Cordula" last="Wagner">Cordula Wagner</name>
<affiliation><inist:fA14 i1="03"><s1>NIVEL Netherlands Institute for Health Services Research</s1>
<s2>Utrecht</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Department of Public and Occupational Health, EMGO+ Institute for Health and Care Research, VU University Medical Center</s1>
<s2>Amsterdam</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Arah, Onyebuchi A" sort="Arah, Onyebuchi A" uniqKey="Arah O" first="Onyebuchi A." last="Arah">Onyebuchi A. Arah</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA)</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Shaw, Charles D" sort="Shaw, Charles D" uniqKey="Shaw C" first="Charles D." last="Shaw">Charles D. Shaw</name>
<affiliation><inist:fA14 i1="06"><s1>University of New South Wales</s1>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kristensen, Solvejg" sort="Kristensen, Solvejg" uniqKey="Kristensen S" first="Solvejg" last="Kristensen">Solvejg Kristensen</name>
<affiliation><inist:fA14 i1="07"><s1>Central Denmark Region & Center for Healthcare Improvements, Aalborg University</s1>
<s3>DNK</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Thompson, Caroline A" sort="Thompson, Caroline A" uniqKey="Thompson C" first="Caroline A." last="Thompson">Caroline A. Thompson</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA)</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="08"><s1>Palo Alto Medical Foundation Research Institute</s1>
<s2>Palo Alto, CA</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dersarkissian, Maral" sort="Dersarkissian, Maral" uniqKey="Dersarkissian M" first="Maral" last="Dersarkissian">Maral Dersarkissian</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA)</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bartels, Paul D" sort="Bartels, Paul D" uniqKey="Bartels P" first="Paul D." last="Bartels">Paul D. Bartels</name>
<affiliation><inist:fA14 i1="09"><s1>Central Denmark Region & The Department of Clinical Medicine, Aalborg University</s1>
<s3>DNK</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pfaff, Holger" sort="Pfaff, Holger" uniqKey="Pfaff H" first="Holger" last="Pfaff">Holger Pfaff</name>
<affiliation><inist:fA14 i1="10"><s1>Institute of Medical Sociology, Health Services Research and Rehabilitation Science, University of Cologne</s1>
<s3>DEU</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Secanell, Mariona" sort="Secanell, Mariona" uniqKey="Secanell M" first="Mariona" last="Secanell">Mariona Secanell</name>
<affiliation><inist:fA14 i1="01"><s1>Avedis Donabedian Research Institute (FAD), Universitat Autonoma de Barcelona</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Red de investigación en servicios de salud en enfermedades crónicas REDISSEC</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mora, Nuria" sort="Mora, Nuria" uniqKey="Mora N" first="Nuria" last="Mora">Nuria Mora</name>
<affiliation><inist:fA14 i1="01"><s1>Avedis Donabedian Research Institute (FAD), Universitat Autonoma de Barcelona</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Red de investigación en servicios de salud en enfermedades crónicas REDISSEC</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vlcek, Frantisek" sort="Vlcek, Frantisek" uniqKey="Vlcek F" first="Frantisek" last="Vlcek">Frantisek Vlcek</name>
<affiliation><inist:fA14 i1="11"><s1>Czech Accreditation Committee</s1>
<s3>CZE</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kutaj Wasikowska, Halina" sort="Kutaj Wasikowska, Halina" uniqKey="Kutaj Wasikowska H" first="Halina" last="Kutaj-Wasikowska">Halina Kutaj-Wasikowska</name>
<affiliation><inist:fA14 i1="12"><s1>Polish Society for Quality Promotion in Health Care</s1>
<s3>POL</s3>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kutryba, Basia" sort="Kutryba, Basia" uniqKey="Kutryba B" first="Basia" last="Kutryba">Basia Kutryba</name>
<affiliation><inist:fA14 i1="12"><s1>Polish Society for Quality Promotion in Health Care</s1>
<s3>POL</s3>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Michel, Philippe" sort="Michel, Philippe" uniqKey="Michel P" first="Philippe" last="Michel">Philippe Michel</name>
<affiliation><inist:fA14 i1="13"><s1>Quality and Safety Department, Lyon University, Hospital Network</s1>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Groene, Oliver" sort="Groene, Oliver" uniqKey="Groene O" first="Oliver" last="Groene">Oliver Groene</name>
<affiliation><inist:fA14 i1="14"><s1>London School of Hygiene and Tropical Medicine</s1>
<s3>GBR</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">International journal for quality in health care</title>
<title level="j" type="abbreviated">Int. j. qual. health care</title>
<idno type="ISSN">1353-4505</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">International journal for quality in health care</title>
<title level="j" type="abbreviated">Int. j. qual. health care</title>
<idno type="ISSN">1353-4505</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Care</term>
<term>Complication</term>
<term>Efficiency</term>
<term>Europe</term>
<term>European</term>
<term>Evidence-based medicine</term>
<term>Healthcare</term>
<term>Hospital</term>
<term>Hospitalization</term>
<term>Iatrogenic</term>
<term>Improvement</term>
<term>Organization</term>
<term>Patient</term>
<term>Patient safety</term>
<term>Professional practice</term>
<term>Public health</term>
<term>Quality</term>
<term>Quality management</term>
<term>Recommendation</term>
<term>Strategy</term>
<term>Variations</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Iatrogène</term>
<term>Médecine factuelle</term>
<term>Organisation</term>
<term>Complication</term>
<term>Malade</term>
<term>Stratégie</term>
<term>Hôpital</term>
<term>Santé publique</term>
<term>Hospitalisation</term>
<term>Europe</term>
<term>Européen</term>
<term>Qualité</term>
<term>Amélioration</term>
<term>Gestion de la qualité</term>
<term>Pratique professionnelle</term>
<term>Variation</term>
<term>Recommandation</term>
<term>Soin</term>
<term>Efficacité</term>
<term>Sécurité du patient</term>
<term>Soins de santé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Objective. To explore how European hospitals have implemented patient safety strategies (PSS) and evidence-based organization of care pathway (EBOP) recommendations and examine the extent to which implementation varies between countries and hospitals. Design. Mixed-method multilevel cross-sectional design in seven countries as part of the European Union-funded project 'Deepening our Understanding of Quality improvement in Europe' (DUQuE). Setting and participants. Seventy-four acute care hospitals with 292 departments managing acute myocardial infarction (AMI), hip fracture, stroke, and obstetric deliveries. Main outcome measure. Five multi-item composite measures-one generic measure for PSS and four pathway-specific measures for EBOP Results. Potassium chloride had only been removed from general medication stocks in 9.4-30.5% of different pathways wards and patients were adequately identified with wristband in 43.0-59.7%. Although 86.3% of areas treating AMI patients had immediate access to a specialist physician, only 56.0% had arrangements for patients to receive thrombolysis within 30 min of arrival at the hospital. A substantial amount of the total variance observed was due to between-hospital differences in the same country for PSS (65.9%). In EBOP, between-country differences play also an important role (10.1%) in AMI to 57.1% in hip fracture). Conclusions. There were substantial gaps between evidence and practice of PSS and EBOP in a sample of European hospitals and variations due to country differences are more important in EBOP than in PSS, but less important than within-country variations. Agencies supporting the implementation of PSS and EBOP should closely re-examine the effectiveness of their current strategies.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>1353-4505</s0>
</fA01>
<fA03 i2="1"><s0>Int. j. qual. health care</s0>
</fA03>
<fA05><s2>26</s2>
</fA05>
<fA06><s3>SUP1</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Evidence-based organization and patient safety strategies in European hospitals</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>How does Hospital Quality Management Drive Quality? Results fror the Deepening our Understanding of Quality Improvement (DUQuE) project</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>SUNOL (Rosa)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>WAGNER (Cordula)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>ARAH (Onyebuchi A.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>SHAW (Charles D.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>KRISTENSEN (Solvejg)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>THOMPSON (Caroline A.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>DERSARKISSIAN (Maral)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>BARTELS (Paul D.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>PFAFF (Holger)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>SECANELL (Mariona)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>MORA (Nuria)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>VLCEK (Frantisek)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>KUTAJ-WASIKOWSKA (Halina)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>KUTRYBA (Basia)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>MICHEL (Philippe)</s1>
</fA11>
<fA11 i1="16" i2="1"><s1>GROENE (Oliver)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>SCHNEIDER (Eric C.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Avedis Donabedian Research Institute (FAD), Universitat Autonoma de Barcelona</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Red de investigación en servicios de salud en enfermedades crónicas REDISSEC</s1>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>NIVEL Netherlands Institute for Health Services Research</s1>
<s2>Utrecht</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Public and Occupational Health, EMGO+ Institute for Health and Care Research, VU University Medical Center</s1>
<s2>Amsterdam</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA)</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>University of New South Wales</s1>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Central Denmark Region & Center for Healthcare Improvements, Aalborg University</s1>
<s3>DNK</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Palo Alto Medical Foundation Research Institute</s1>
<s2>Palo Alto, CA</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Central Denmark Region & The Department of Clinical Medicine, Aalborg University</s1>
<s3>DNK</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Institute of Medical Sociology, Health Services Research and Rehabilitation Science, University of Cologne</s1>
<s3>DEU</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>Czech Accreditation Committee</s1>
<s3>CZE</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>Polish Society for Quality Promotion in Health Care</s1>
<s3>POL</s3>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>Quality and Safety Department, Lyon University, Hospital Network</s1>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="14"><s1>London School of Hygiene and Tropical Medicine</s1>
<s3>GBR</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>RAND Boston</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Division of General Medicine and Primary Care, Brigham and Women's Hospital and Harvard School of Public Health</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA17 i1="01" i2="1"><s1>DUQUE PROJECT CONSORTIUM </s1>
<s3>NLD</s3>
</fA17>
<fA20><s1>47-55</s1>
</fA20>
<fA21><s1>2014</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>22943</s2>
<s5>354000502708920060</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2014 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>35 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>14-0152847</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>International journal for quality in health care</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Objective. To explore how European hospitals have implemented patient safety strategies (PSS) and evidence-based organization of care pathway (EBOP) recommendations and examine the extent to which implementation varies between countries and hospitals. Design. Mixed-method multilevel cross-sectional design in seven countries as part of the European Union-funded project 'Deepening our Understanding of Quality improvement in Europe' (DUQuE). Setting and participants. Seventy-four acute care hospitals with 292 departments managing acute myocardial infarction (AMI), hip fracture, stroke, and obstetric deliveries. Main outcome measure. Five multi-item composite measures-one generic measure for PSS and four pathway-specific measures for EBOP Results. Potassium chloride had only been removed from general medication stocks in 9.4-30.5% of different pathways wards and patients were adequately identified with wristband in 43.0-59.7%. Although 86.3% of areas treating AMI patients had immediate access to a specialist physician, only 56.0% had arrangements for patients to receive thrombolysis within 30 min of arrival at the hospital. A substantial amount of the total variance observed was due to between-hospital differences in the same country for PSS (65.9%). In EBOP, between-country differences play also an important role (10.1%) in AMI to 57.1% in hip fracture). Conclusions. There were substantial gaps between evidence and practice of PSS and EBOP in a sample of European hospitals and variations due to country differences are more important in EBOP than in PSS, but less important than within-country variations. Agencies supporting the implementation of PSS and EBOP should closely re-examine the effectiveness of their current strategies.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B30A01D</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B30A11</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Iatrogène</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Iatrogenic</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Iatrógeno</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Médecine factuelle</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Evidence-based medicine</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Medicina basada en pruebas</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Organisation</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Organization</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Organización</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Complication</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Complication</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Complicación</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Malade</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Patient</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Enfermo</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Stratégie</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Strategy</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Estrategia</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Hôpital</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Hospital</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Hospital</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Public health</s0>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Hospitalisation</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Hospitalization</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Hospitalización</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Europe</s0>
<s2>NG</s2>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Europe</s0>
<s2>NG</s2>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Europa</s0>
<s2>NG</s2>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Européen</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>European</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Europeo</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Qualité</s0>
<s5>19</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Quality</s0>
<s5>19</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Calidad</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Amélioration</s0>
<s5>20</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Improvement</s0>
<s5>20</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Mejora</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Gestion de la qualité</s0>
<s5>21</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Quality management</s0>
<s5>21</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Gestión de calidad</s0>
<s5>21</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Pratique professionnelle</s0>
<s5>22</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Professional practice</s0>
<s5>22</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Práctica profesional</s0>
<s5>22</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Variation</s0>
<s5>23</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Variations</s0>
<s5>23</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Variación</s0>
<s5>23</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE"><s0>Recommandation</s0>
<s5>24</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG"><s0>Recommendation</s0>
<s5>24</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA"><s0>Recomendación</s0>
<s5>24</s5>
</fC03>
<fC03 i1="18" i2="X" l="FRE"><s0>Soin</s0>
<s5>25</s5>
</fC03>
<fC03 i1="18" i2="X" l="ENG"><s0>Care</s0>
<s5>25</s5>
</fC03>
<fC03 i1="18" i2="X" l="SPA"><s0>Cuidado</s0>
<s5>25</s5>
</fC03>
<fC03 i1="19" i2="X" l="FRE"><s0>Efficacité</s0>
<s5>26</s5>
</fC03>
<fC03 i1="19" i2="X" l="ENG"><s0>Efficiency</s0>
<s5>26</s5>
</fC03>
<fC03 i1="19" i2="X" l="SPA"><s0>Eficacia</s0>
<s5>26</s5>
</fC03>
<fC03 i1="20" i2="X" l="FRE"><s0>Sécurité du patient</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="20" i2="X" l="ENG"><s0>Patient safety</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="21" i2="X" l="FRE"><s0>Soins de santé</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC03 i1="21" i2="X" l="ENG"><s0>Healthcare</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC03 i1="21" i2="X" l="SPA"><s0>Asistencia sanitaria</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pratique basée sur des preuves</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Evidence-based practice</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Práctica basada en la evidencia</s0>
</fC07>
<fN21><s1>195</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 14-0152847 INIST</NO>
<ET>Evidence-based organization and patient safety strategies in European hospitals</ET>
<AU>SUNOL (Rosa); WAGNER (Cordula); ARAH (Onyebuchi A.); SHAW (Charles D.); KRISTENSEN (Solvejg); THOMPSON (Caroline A.); DERSARKISSIAN (Maral); BARTELS (Paul D.); PFAFF (Holger); SECANELL (Mariona); MORA (Nuria); VLCEK (Frantisek); KUTAJ-WASIKOWSKA (Halina); KUTRYBA (Basia); MICHEL (Philippe); GROENE (Oliver); SCHNEIDER (Eric C.)</AU>
<AF>Avedis Donabedian Research Institute (FAD), Universitat Autonoma de Barcelona/Espagne (1 aut., 10 aut., 11 aut.); Red de investigación en servicios de salud en enfermedades crónicas REDISSEC/Espagne (1 aut., 10 aut., 11 aut.); NIVEL Netherlands Institute for Health Services Research/Utrecht/Pays-Bas (2 aut.); Department of Public and Occupational Health, EMGO+ Institute for Health and Care Research, VU University Medical Center/Amsterdam/Pays-Bas (2 aut.); Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA)/Los Angeles, CA/Etats-Unis (3 aut., 6 aut., 7 aut.); University of New South Wales/Australie (4 aut.); Central Denmark Region & Center for Healthcare Improvements, Aalborg University/Danemark (5 aut.); Palo Alto Medical Foundation Research Institute/Palo Alto, CA/Etats-Unis (6 aut.); Central Denmark Region & The Department of Clinical Medicine, Aalborg University/Danemark (8 aut.); Institute of Medical Sociology, Health Services Research and Rehabilitation Science, University of Cologne/Allemagne (9 aut.); Czech Accreditation Committee/Tchèque, République (12 aut.); Polish Society for Quality Promotion in Health Care/Pologne (13 aut., 14 aut.); Quality and Safety Department, Lyon University, Hospital Network/France (15 aut.); London School of Hygiene and Tropical Medicine/Royaume-Uni (16 aut.); RAND Boston/Etats-Unis (1 aut.); Division of General Medicine and Primary Care, Brigham and Women's Hospital and Harvard School of Public Health/Etats-Unis (1 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>International journal for quality in health care; ISSN 1353-4505; Royaume-Uni; Da. 2014; Vol. 26; No. SUP1; Pp. 47-55; Bibl. 35 ref.</SO>
<LA>Anglais</LA>
<EA>Objective. To explore how European hospitals have implemented patient safety strategies (PSS) and evidence-based organization of care pathway (EBOP) recommendations and examine the extent to which implementation varies between countries and hospitals. Design. Mixed-method multilevel cross-sectional design in seven countries as part of the European Union-funded project 'Deepening our Understanding of Quality improvement in Europe' (DUQuE). Setting and participants. Seventy-four acute care hospitals with 292 departments managing acute myocardial infarction (AMI), hip fracture, stroke, and obstetric deliveries. Main outcome measure. Five multi-item composite measures-one generic measure for PSS and four pathway-specific measures for EBOP Results. Potassium chloride had only been removed from general medication stocks in 9.4-30.5% of different pathways wards and patients were adequately identified with wristband in 43.0-59.7%. Although 86.3% of areas treating AMI patients had immediate access to a specialist physician, only 56.0% had arrangements for patients to receive thrombolysis within 30 min of arrival at the hospital. A substantial amount of the total variance observed was due to between-hospital differences in the same country for PSS (65.9%). In EBOP, between-country differences play also an important role (10.1%) in AMI to 57.1% in hip fracture). Conclusions. There were substantial gaps between evidence and practice of PSS and EBOP in a sample of European hospitals and variations due to country differences are more important in EBOP than in PSS, but less important than within-country variations. Agencies supporting the implementation of PSS and EBOP should closely re-examine the effectiveness of their current strategies.</EA>
<CC>002B30A01D; 002B30A11</CC>
<FD>Iatrogène; Médecine factuelle; Organisation; Complication; Malade; Stratégie; Hôpital; Santé publique; Hospitalisation; Europe; Européen; Qualité; Amélioration; Gestion de la qualité; Pratique professionnelle; Variation; Recommandation; Soin; Efficacité; Sécurité du patient; Soins de santé</FD>
<FG>Pratique basée sur des preuves</FG>
<ED>Iatrogenic; Evidence-based medicine; Organization; Complication; Patient; Strategy; Hospital; Public health; Hospitalization; Europe; European; Quality; Improvement; Quality management; Professional practice; Variations; Recommendation; Care; Efficiency; Patient safety; Healthcare</ED>
<EG>Evidence-based practice</EG>
<SD>Iatrógeno; Medicina basada en pruebas; Organización; Complicación; Enfermo; Estrategia; Hospital; Salud pública; Hospitalización; Europa; Europeo; Calidad; Mejora; Gestión de calidad; Práctica profesional; Variación; Recomendación; Cuidado; Eficacia; Asistencia sanitaria</SD>
<LO>INIST-22943.354000502708920060</LO>
<ID>14-0152847</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000399 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000399 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:14-0152847
   |texte=   Evidence-based organization and patient safety strategies in European hospitals
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Evidence-based organization and patient safety strategies in European hospitals

Evidence-based organization and patient safety strategies in European hospitals

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri